Arndt Hartmann - Concepedia

Author

Arndt Hartmann

Also Known As

A Hartmann, A. Hartmann, A.-R. Hartmann, ARNDT HARTMANN, Antonia Hartmann, Arndt Hartmann, Bernd Wullich, Christine Stoehr, Hartmann, Arndt, Helge Taubert

303

Publications

39.7K

Citations

H-Index

104

Concepts

All Affiliations

University of Regensburg Friedrich-Alexander-Universität Erlangen-Nürnberg Universitätsklinikum Erlangen University of Vermont University of Basel

About

Arndt Hartmann is an author at University of Regensburg specializing in medicine, pathology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	58	4.7K
2	Engineering	4	4	1.3K
3	Health Sciences	4	4	224
4	Public Health	3	3	101
5	Biostatistics	2	2	176

Arndt Hartmann

126

Publications

8.8K

Citations

H-Index

Page 1

	Year	Citations
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Kyle Ellrott, Matthew H. Bailey, Gordon Saksena, Cell Systems EngineeringGeneticsGenomicsArtifact FilteringTcga Data	2018	895
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies Xiaohong R. Yang, Jenny Chang‐Claude, Ellen L. Goode, JNCI Journal of the National Cancer Institute	2010	711
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas Franz X. Schaub, Varsha Dhankani, Ashton C. Berger, Cell Systems	2018	434
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis Gad Singer, Robert Stöhr, Leslie Cope, The American Journal of Surgical Pathology Mutational StatusUrologyNew ModelTumor HeterogeneityInvasive Mpscs	2005	406
WIF1, a component of the Wnt pathway, is down‐regulated in prostate, breast, lung, and bladder cancer Christoph Wissmann, Peter J. Wild, Simone Kaiser, The Journal of Pathology EngineeringPathologyCancer BiologyTumor BiologyChip Hybridization	2003	332
A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease Marcus Mühlbauer, Anja‐Katrin Bosserhoff, Arndt Hartmann, Gastroenterology Hepatic DisordersHepatologyViral HepatitisLiver PhysiologyPathogenesis	2003	207
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort† J. Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, European Urology	2019	189
EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees Alan Horwich, Marek Babjuk, Joaquim Bellmunt, Annals of Oncology UrologyGenitourinary CancerEau–esmo Consensus StatementsMedicineCancer Management	2019	180
Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors Eva Klopocki, Glen Kristiansen, Peter J. Wild, International Journal of Oncology Breast OncologyPathologyCancer BiologyTumor BiologyBreast Cancer Progression	2004	174
Seven Years’ Experience with 5-Aminolevulinic Acid in Detection of Transitional Cell Carcinoma of the Bladder Edwin Hungerhuber, Herbert Stepp, M. Kriegmair, Urology Tumor BiologyUrological ResearchUrologyTransitional Cell CarcinomaGenitourinary Cancer	2007	157

Page 1